von Willebrand factor antigen in blood plasma of patients with urinary bladder carcinoma

Thrombosis Research

Volumn 83, Issue 5, 1996, Pages 399-402

  Ziȩtek, Zbigniew ^a   Iwan Ziȩtek, Iza ^a   Paczulski, Ryszard ^a   Kotschy, Maria ^a   Wolski, Zbigniew ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Bladder carcinoma; von Willebrand factor antigen

Indexed keywords

VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0030248474     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00149-1     Document Type: Article

References (18)

1. 1. Sweeney, J.P., Killion, K.M., Pruet, C.F. and Apaulding, M.B. Von Willebrand factor in head and neck cancer. Cancer 11, 2387-2389, 1990.
2. 2. Rahr, H.B., Sorensen, J.V., Larsen, J.F., Svendsen Jensen, F., Bredahl, C. and Nieuwenhnizen, W. Haemostatic activation before and after surgery in patients with and without gastric malignancy. Thromb Haemosts 71, 713-718, 1994.
3. 3. Zacharski, L.R., Memoli, V.A., Ornstein, D.L., Rousseau, S.M., Kisiel, W. and Kudryk, B.J. Tumor cell procoagulant and urokinase expression in carcinoma of the ovary. J Natl Can Inst 15, 1225-1230, 1993.
4. 4. Yoshida, E., Verrusio, E.N., Mihora, H., Oh, D. and Kwaan, H.C. Enhancement of the expression of urokinase-type plasminogen activator from PC-3 human prostate cancer cells by thrombin. Cancer Res 59, 3300-3304, 1994.
5. 5. Nierodzik, M.L., Plotkin, A., Kajumo, F. and Karpatkin, S. Thrombin stimulates tumor -platelet adhesion in vitro and metastasis in vivo. J Clin Invest 87, 229-236, 1991.
6. 6. Monschke, F., Muller, W.U., Winklar, U. and Streffer, C. Cell proliferation and vascularization in human breast carcinoma. Int J Cancer 49, 812-815, 1991.
7. 7. Noguchi, Y. Blood vessel invasion in gastric carcinoma. Surgery 107, 140-148, 1990.
8. 1 transitional carcinoma of bladder. Histopathology 19, 551-554, 1991.
9. 9. Gordon, S.G. Cancer cell procoagulants and their role in malignant disease. Semin Thromb Hemostas 14, 424-433, 1992.
10. 10. Bradley, L.A., Franco, E.L. and Reisner, H.M. Use of monoclonal antibodies in an enzyme immunoassay for factor VIII-related antigen. Clin Chem 30, 87-92, 1984.
11. 11. Zacharski, L.R., Schned, A.R. and Sorenson, G.D. Occurence of fibrin and tissue factor antigen in human cell carcinoma of the lung. Cancer Res 43, 3963-3968, 1983.
12. 12. Wojtukiewicz, M.Z., Zacharski, L.R., Memoli, V.A., Kisiel, W., Kudryk, B.J., Rousseau, S.M. and Strump, D.C. Indirect activation of blood coagulation in colon cancer. Thromb Haemostas 62, 1062-1066, 1989.
13. 13. Dvorak, H.F., Dickersin, G.R., Dvorak, A.M., Manseau, E.J. and Pyne, K. Human breast carcinoma: fibrin deposits and desmoplasia inflammatory cell type and distribution. Microvasculature and infarction. J Natl Can Inst 67, 335-345, 1981.
14. 14. Long, L., Jonasson, O., Roberts, S., McGrath, R., McGrow, E. and Cole, W.E. Cancer cells in blood. Results of a simplified isolation technique. Arch Surg 80, 910-919, 1960.
15. 15 Zhou, Q.S., Zhao, Y.M., Xu, C.S., Yu, Z.Y., Yao, D.Y., Gao, Y.M. and Ruan, C.G. Increase in plasma thrombomodulin and decrease in plasma von Willebrand factor after regular radiotherapy of patients with cancer. Thromb Res 68, 109-118, 1992.
16. 16. Fregene, T.A., Khanuja, P.S., Noto, A.C., Gehani, S.K., Van-Egmont, E.M., Luz, D.A. and Pienta, K.J. Tumor associated angiogenesis in prostate cancer. Anticancer Res 13, 2377-2381, 1993.
17. 17. Gadducci, A., Baicchi, U., Marrai, R., del-Bravo, B., Fosella, P.V. and Facchini, V. Pretreatment plasma levels of fibrinopepitde-A (FpA), D-dimer (DD), and von Willebrand factor (vWF) in patients with ovarian carcinoma. Gynecol Oncol 53, 352-356, 1994.
18. 18. Gadducci, A., Baicchi, U., Marrai, R., Facchini, V., del-Bravo, B., Fosella, P.V. and Fioretti, P. Pretreatment plasma levels of fibrinopeptide-A (FpA), D-dimer (DD), and von Willebrand factor (vWF) in patients with operable cervical cancer: influence of surgical-pathological stage, tumor size, histologic type, and lymph node status. Gynecol Oncol 49, 354-358, 1993.